Comments
Loading...
Madrigal Pharmaceuticals Rapporto sugli interessi allo scoperto
MDGLNASDAQ
Report sulle vendite allo scoperto
Il short interest su Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 3.79M a 3.98M. Questo rappresenta il 20.69% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Madrigal Pharmaceuticals Corp (XNAS:MDGL) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 450.80K azioni scambiate al giorno, ci vorrebbero 8.83 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
3.98M
Vendite allo scoperto %
20.7%
Giorni di copertura
8.83
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
MDGL | Madrigal Pharmaceuticals, Inc. | 07/31/2025 | 08/11/2025 | 20.69% | 19,238,713 | 3,980,199 | 450,798 | 8.83 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 07/15/2025 | 07/24/2025 | 19.77% | 19,152,981 | 3,787,367 | 236,184 | 16.04 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 06/30/2025 | 07/10/2025 | 20.71% | 19,152,981 | 3,966,696 | 325,607 | 12.18 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 06/13/2025 | 06/25/2025 | 21.68% | 19,152,981 | 4,152,509 | 299,276 | 13.88 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 05/30/2025 | 06/10/2025 | 20.29% | 19,152,981 | 3,885,358 | 321,652 | 12.08 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 05/15/2025 | 05/27/2025 | 20.89% | 19,152,981 | 4,000,742 | 387,419 | 10.33 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 04/30/2025 | 05/09/2025 | 21.43% | 19,152,981 | 4,104,430 | 359,109 | 11.43 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 04/15/2025 | 04/25/2025 | 26.04% | 15,465,589 | 4,027,147 | 349,950 | 11.51 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 03/31/2025 | 04/09/2025 | 25.85% | 15,465,589 | 3,997,671 | 235,748 | 16.96 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 03/14/2025 | 03/25/2025 | 26.47% | 15,465,589 | 4,094,246 | 479,995 | 8.53 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 02/28/2025 | 03/11/2025 | 24.27% | 15,465,589 | 3,753,213 | 431,065 | 8.71 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 02/14/2025 | 02/26/2025 | 24.54% | 15,465,589 | 3,795,295 | 354,573 | 10.7 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 01/31/2025 | 02/11/2025 | 26.21% | 15,195,750 | 3,982,712 | 465,120 | 8.56 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 01/15/2025 | 01/27/2025 | 26.87% | 15,195,750 | 4,083,736 | 454,640 | 8.98 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 12/31/2024 | 01/10/2025 | 27.02% | 15,195,750 | 4,106,529 | 325,210 | 12.63 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 12/13/2024 | 12/24/2024 | 31.15% | 15,195,750 | 4,734,136 | 295,218 | 16.04 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 11/29/2024 | 12/10/2024 | 28.17% | 15,195,750 | 4,281,332 | 377,901 | 11.33 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 11/15/2024 | 11/26/2024 | 29.18% | 15,195,750 | 4,434,650 | 819,575 | 5.41 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 10/31/2024 | 11/11/2024 | 29.83% | 15,195,750 | 4,532,914 | 362,617 | 12.5 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 10/15/2024 | 10/24/2024 | 26.84% | 15,098,020 | 4,051,836 | 282,118 | 14.36 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 09/30/2024 | 10/09/2024 | 25.58% | 15,098,020 | 3,862,050 | 279,603 | 13.81 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 09/13/2024 | 09/24/2024 | 24.70% | 15,098,020 | 3,728,767 | 208,382 | 17.89 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 08/30/2024 | 09/11/2024 | 24.89% | 15,098,020 | 3,758,394 | 187,886 | 20 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 07/31/2024 | 08/09/2024 | 24.39% | 15,098,020 | 3,681,731 | 261,053 | 14.1 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 07/15/2024 | 07/24/2024 | 27.94% | 14,696,869 | 4,106,956 | 252,216 | 16.28 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 06/28/2024 | 07/10/2024 | 27.73% | 14,696,869 | 4,075,862 | 405,598 | 10.05 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 06/14/2024 | 06/26/2024 | 30.17% | 14,696,869 | 4,434,720 | 789,334 | 5.62 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 05/31/2024 | 06/11/2024 | 35.58% | 14,696,869 | 5,228,915 | 397,253 | 13.16 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 05/15/2024 | 05/24/2024 | 28.36% | 14,696,869 | 4,168,108 | 419,199 | 9.94 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 04/30/2024 | 05/09/2024 | 27.08% | 14,696,869 | 3,979,870 | 459,048 | 8.67 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 04/15/2024 | 04/24/2024 | 23.22% | 14,669,941 | 3,406,240 | 344,653 | 9.88 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 03/28/2024 | 04/09/2024 | 19.04% | 17,659,598 | 3,362,431 | 543,592 | 6.19 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 03/15/2024 | 03/26/2024 | 18.83% | 17,313,445 | 3,260,672 | 843,521 | 3.87 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 02/29/2024 | 03/11/2024 | 20.89% | 16,585,443 | 3,464,813 | 498,589 | 6.95 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 02/15/2024 | 02/27/2024 | 20.62% | 16,430,664 | 3,387,887 | 843,732 | 4.02 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 01/31/2024 | 02/09/2024 | 19.13% | 16,430,664 | 3,142,610 | 277,628 | 11.32 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 01/12/2024 | 01/24/2024 | 20.12% | 16,430,664 | 3,305,721 | 296,803 | 11.14 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 12/29/2023 | 01/10/2024 | 19.80% | 16,430,664 | 3,252,646 | 296,721 | 10.96 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 12/15/2023 | 12/27/2023 | 18.69% | 16,430,664 | 3,070,502 | 475,756 | 6.45 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 11/30/2023 | 12/11/2023 | 21.15% | 16,430,664 | 3,474,558 | 342,110 | 10.16 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 11/15/2023 | 11/27/2023 | 21.03% | 16,430,664 | 3,455,094 | 461,325 | 7.49 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 10/31/2023 | 11/09/2023 | 20.76% | 16,430,664 | 3,411,270 | 390,972 | 8.73 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 10/13/2023 | 10/24/2023 | 18.35% | 16,407,349 | 3,010,022 | 568,731 | 5.29 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 09/29/2023 | 10/10/2023 | 16.12% | 16,407,349 | 2,645,340 | 506,992 | 5.22 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 09/15/2023 | 09/26/2023 | 14.06% | 15,159,251 | 2,131,676 | 508,623 | 4.19 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 08/31/2023 | 09/12/2023 | 12.94% | 15,159,251 | 1,961,334 | 194,020 | 10.11 | |
MDGL | Madrigal Pharmaceuticals, Inc. | 08/15/2023 | 08/24/2023 | 11.93% | 15,159,251 | 1,808,199 | 316,648 | 5.71 |
In cerca di azioni più vendute allo scoperto?